&Partners’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

&Partners’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.34M	Sell	85,761 -1,495	-2%	-$21.5K	0.01%	1250
2026 Q1	$1.25M	Buy	87,256 +17,999	+26%	+$267K	0.01%	1170
2025 Q4	$1.04M	Buy	69,257 +53,558	+341%	+$804K	0.01%	1199
2025 Q3	$226K	Buy	15,699 +1,019	+7%	+$14.5K	﹤0.01%	1905
2025 Q2	$209K	Sell	14,680 -403	-3%	-$5.76K	﹤0.01%	1814
2025 Q1	$225K	Buy	15,083 +2,733	+22%	+$42.8K	﹤0.01%	1567
2024 Q4	$185K	Buy	12,350 +1,613	+15%	+$25K	﹤0.01%	1551
2024 Q3	$170K	Buy	+10,737	New	+$169K	﹤0.01%	1329

Other funds holding BMEZ

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

&Partners's BMEZ Position: Q2 2026 in Review

&Partners reduced its BlackRock Health Sciences Trust II (BMEZ) stake by 1.7% in Q2 2026, selling an estimated $21.5K and leaving 85,761 shares worth $1.34M. The position accounts for 0.01% of the portfolio, ranked #1250.

&Partners first reported a position in BMEZ in Q3 2024 and has held it in 8 quarters since. 89 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

&Partners held 85,761 shares of BlackRock Health Sciences Trust II worth $1.34M as of Q2 2026.
&Partners sold 1,495 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $21.5K.
BlackRock Health Sciences Trust II made up 0.01% of &Partners's portfolio in Q2 2026, its #1250 holding.
&Partners first reported a position in BlackRock Health Sciences Trust II in Q3 2024 and has held it in 8 quarters since.
89 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.